Therapeutic Solutions International, Inc. (TSOI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.05 Million | -1.01 Million | -718.92 Thousand | -663.07 Thousand | -310.71 Thousand | -469.17 Thousand |
| Net Income | -2.16 Million | -3.67 Million | -2.96 Million | -2.19 Million | -1.69 Million | -1.86 Million |
| Depreciation & Amortization | 311.77 Thousand | 244.63 Thousand | 18.06 Thousand | 6980.00 | 6591.00 | 194.98 Thousand |
| Deferred income taxes | -102.44 Million | - | 44.5 Thousand | 24.64 Thousand | 303.41 Thousand | 230.36 Thousand |
| Stock-based compensation | 395.54 Thousand | 1.64 Million | 1.33 Million | 1.16 Million | 468 Thousand | 623.25 Thousand |
| Change in working capital | 264.63 Thousand | 337.79 Thousand | 299.3 Thousand | 87.75 Thousand | 330.01 Thousand | 143.77 Thousand |
| Other non-cash items | 102.58 Million | 433.81 Thousand | 541.61 Thousand | 251.8 Thousand | 278.59 Thousand | 205.36 Thousand |
| Investing Cash Flow | -24 Thousand | - | -256.55 Thousand | -5448.00 | - | - |
| Investments in PPE | -16.15 Thousand | - | -260.56 Thousand | -5448.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -7843.00 | - | 4015.00 | - | - | - |
| Financing Cash Flow | 1.07 Million | 943.08 Thousand | 817.38 Thousand | 894.27 Thousand | 314.74 Thousand | 491.54 Thousand |
| Debt repayment | -287.24 Thousand | -6912.00 | -6867.00 | -25.24 Thousand | -36.68 Thousand | -2460.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 790.43 Thousand | 445 Thousand | 285.49 Thousand | 588.04 Thousand | 76.43 Thousand | 249 Thousand |
| Other Financing Activities | 287.24 Million | 505 Thousand | 538.75 Thousand | 331.47 Thousand | 275 Thousand | 245 Thousand |
| Accounts receivables | 6202.00 | -8785.00 | -14.17 Thousand | 463.00 | -2904.00 | 204.36 Thousand |
| Accounts payables | -4325.00 | 5375.00 | 94.13 Thousand | -27.96 Thousand | 8856.00 | -15.01 Thousand |
| Inventory | 19.85 Thousand | -2611.00 | -34.41 Thousand | -219.00 | -5180.00 | 1515.00 |
| Other working capital | 242.9 Thousand | 343.81 Thousand | 253.75 Thousand | 115.47 Thousand | 329.23 Thousand | -47.08 Thousand |
| Cash at beginning of period | 29.43 Thousand | 104.25 Thousand | 262.34 Thousand | 36.59 Thousand | 32.57 Thousand | 10.2 Thousand |
| Cash at end of period | 27.82 Thousand | 29.04 Thousand | 104.25 Thousand | 262.34 Thousand | 36.59 Thousand | 32.57 Thousand |
| Capital Expenditure | -16.15 Thousand | - | -260.56 Thousand | -5448.00 | - | - |
| Effect of forex changes on cash | -1.61 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -1614.00 | -75.21 Thousand | -158.09 Thousand | 225.75 Thousand | 4027.00 | 22.36 Thousand |
| Free Cash Flow | -1.07 Million | -1.01 Million | -979.48 Thousand | -668.52 Thousand | -310.71 Thousand | -469.17 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -390.04 Thousand | -585.14 Thousand | -427.49 Thousand | -2.16 Million | -602.85 Thousand | -563.25 Thousand |
| Depreciation & Amortization | 76.91 Thousand | 76.91 Thousand | 81.03 Thousand | 311.77 Thousand | 76.91 Thousand | 76.91 Thousand |
| Deferred income taxes | - | - | -328.86 Thousand | -102.44 Million | 62.46 Thousand | -102.31 Thousand |
| Stock-based compensation | 25.38 Thousand | 1.17 Million | 196.41 Thousand | 395.54 Thousand | 18.37 Thousand | 100.21 Thousand |
| Change in working capital | 170.5 Thousand | -775.21 Thousand | 85.39 Thousand | 264.63 Thousand | 56.45 Thousand | 36.3 Thousand |
| Other non-cash items | 159.09 Thousand | 1.24 Million | 187.47 Thousand | 102.58 Million | 77.58 Thousand | 115.02 Thousand |
| Investing Cash Flow | - | - | -4335.00 | -24 Thousand | -18.86 Thousand | -2751.00 |
| Investments in PPE | 3.00 | - | -16.14 Million | -16.15 Thousand | -16.15 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -4335.00 | -7843.00 | -2708.00 | -2751.00 |
| Financing Cash Flow | 98.25 Thousand | 231.16 Thousand | 147.65 Thousand | 1.07 Million | 297 Thousand | 433.4 Thousand |
| Debt repayment | -63.49 Thousand | -72.07 Thousand | -34.59 Thousand | -287.24 Thousand | -1274.00 | -1222.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 34.76 Thousand | 159.09 Thousand | 113.05 Thousand | 790.43 Thousand | 189.02 Thousand | 358.26 Thousand |
| Other Financing Activities | 99.22 Thousand | 221.16 Million | 148.95 Thousand | 287.24 Million | 109.24 Thousand | 76.36 Thousand |
| Accounts receivables | 871.00 | 1036.00 | 2568.00 | 6202.00 | -4185.00 | 147.00 |
| Accounts payables | -8359.00 | -19.61 Thousand | 23.21 Thousand | -4325.00 | 19.08 Thousand | -36.34 Thousand |
| Inventory | 1432.00 | 3336.00 | 3844.00 | 19.85 Thousand | 4974.00 | 4293.00 |
| Other working capital | 176.56 Thousand | -759.97 Thousand | 55.77 Thousand | 242.9 Thousand | 36.57 Thousand | 68.21 Thousand |
| Cash at beginning of period | 53.47 Thousand | 27.82 Thousand | 90.13 Thousand | 29.43 Thousand | 123.08 Thousand | 29.53 Thousand |
| Cash at end of period | 8318.00 | 53.47 Thousand | 27.82 Thousand | 27.82 Thousand | 90.13 Thousand | 123.08 Thousand |
| Capital Expenditure | 3.00 | - | -16.14 Million | -16.15 Thousand | -16.15 Thousand | - |
| Effect of forex changes on cash | - | - | 394.00 | -1.61 Million | - | - |
| Net cash flow / Change in cash | -45.15 Thousand | 25.65 Thousand | -62.31 Thousand | -1614.00 | -32.94 Thousand | 93.54 Thousand |
| Free Cash Flow | -143.41 Thousand | -205.5 Thousand | -16.34 Million | -1.07 Million | -327.23 Thousand | -337.1 Thousand |
TRINL
0R30
MIHL
CDM1
TITLE
GSJ